Akso Health Group’s shares slid to a 52-week low of $1.03 on Tuesday, extending a year-long downturn that has erased roughly a third of the company’s market value.
The stock has fallen 31% over the past 12 months and is down 26% year-to-date, according to market data. In the latest week alone, shares have dropped nearly 12%, deepening the decline from a prior weekly loss of 13% reported earlier.
The company’s gross profit margin has turned negative at -0.08%, reflecting ongoing profitability challenges. InvestingPro analysis indicates the stock exhibits high volatility and has remained unprofitable over the last twelve months. The shares are also flagged as overvalued relative to their fair value, placing them among the platform’s most overvalued listings.
The latest low underscores broader pressures within the healthcare sector and wider economic headwinds affecting investor sentiment.
